Viewing Study NCT00442312


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-26 @ 10:17 PM
Study NCT ID: NCT00442312
Status: UNKNOWN
Last Update Posted: 2007-03-01
First Post: 2007-02-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
Sponsor: Genovate Biotechnology Co., Ltd.,
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module